304 related articles for article (PubMed ID: 11509605)
1. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
[TBL] [Abstract][Full Text] [Related]
3. MHC class I-restricted presentation of maleylated protein binding to scavenger receptors.
Bansal P; Mukherjee P; Basu SK; George A; Bal V; Rath S
J Immunol; 1999 Apr; 162(8):4430-7. PubMed ID: 10201979
[TBL] [Abstract][Full Text] [Related]
4. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
[TBL] [Abstract][Full Text] [Related]
5. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
6. MHC class II presentation of endogenous tumor antigen by cellular vaccines depends on the endocytic pathway but not H2-M.
Qi L; Ostrand-Rosenberg S
Traffic; 2000 Feb; 1(2):152-60. PubMed ID: 11208095
[TBL] [Abstract][Full Text] [Related]
7. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
8. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
9. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
[TBL] [Abstract][Full Text] [Related]
10. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
[TBL] [Abstract][Full Text] [Related]
11. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
[TBL] [Abstract][Full Text] [Related]
12. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
Dissanayake SK; Tuera N; Ostrand-Rosenberg S
J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
[TBL] [Abstract][Full Text] [Related]
13. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen Z; Reznikoff G; Dranoff G; Rock KL
J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
[TBL] [Abstract][Full Text] [Related]
14. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
15. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes.
Muno D; Kominami E; Mizuochi T
FEBS Lett; 2000 Jul; 478(1-2):178-82. PubMed ID: 10922492
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.
Serna A; Ramirez MC; Soukhanova A; Sigal LJ
J Immunol; 2003 Dec; 171(11):5668-72. PubMed ID: 14634072
[TBL] [Abstract][Full Text] [Related]
17. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
18. Antigen secreted from noncytosolic Listeria monocytogenes is processed by the classical MHC class I processing pathway.
Zwickey HL; Potter TA
J Immunol; 1999 Jun; 162(11):6341-50. PubMed ID: 10352246
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
Lich JD; Elliott JF; Blum JS
J Exp Med; 2000 May; 191(9):1513-24. PubMed ID: 10790426
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]